Emma Hamilton

Dr. Emma Hamilton is a Senior Lecturer in the UWA Medical School, Faculty of Health and Medical Sciences at the University of Western Australia. She earned her MBBS, became a Fellow of the Royal Australasian College of Physicians (FRACP), and completed a PhD at the University of Melbourne titled “Control of Musculoskeletal Function and Body Composition by Androgens in Males,” supervised by Professor Jeffrey Zajac and Dr. Mathis Grossmann at Austin Health. Having undertaken her endocrinology training in Western Australia, she practices as an Endocrinologist at Fiona Stanley and Fremantle Hospitals. Dr. Hamilton is the Endocrinology Lead of the Multidisciplinary Diabetes Foot Ulcer Unit at Fiona Stanley Hospital, an NADC Centre of Excellence interdisciplinary High Risk Foot Service, and holds an adjunct Clinical Senior Lecturer position at UWA.

Dr. Hamilton's research interests include diabetes, endocrinology, diabetes complications, osteoporosis, and testosterone, with a primary focus on diabetes-related foot disease. She received the Raine Clinician Research Fellowship to enhance clinical outcomes for patients with diabetes foot complications. As Chair of Diabetes Feet Australia, she contributes to key national initiatives such as the NADC Diabetic Foot Network working party, NADC interdisciplinary High Risk Foot Service accreditation committee, Foot Forward Executive Advisory team, DFA Australian Research Priorities project, DFA Australian guidelines Wound Classification group, and the International Working Group on the Diabetic Foot (IWGDF) Wound Classification guideline group. Her research has amassed over 1,600 citations. Notable publications are "Medial arterial calcification of the foot arteries is associated with incident cardiovascular events or all-cause mortality in patients with diabetes-related foot ulceration" (2026, Diabetes Research and Clinical Practice), "Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers" (2025, Diabetologia), "The combined impact of chronic kidney disease and ulcer severity on incident cardiovascular events in patients with diabetes-related foot ulceration" (2025, Physiological Reports), "Achievement of low-density lipoprotein cholesterol goals in patients with diabetes-related foot ulceration" (2025, Journal of Diabetes and Its Complications), "Temporal Trends in Distal Symmetric Polyneuropathy in Type 2 Diabetes: Fremantle Diabetes Study Phase II" (2024, Journal of Clinical Endocrinology & Metabolism), and "Diabetes-related foot disease: new insights with an endocrinological perspective" (2023, Journal of Endocrinology).

Professional Email: emma.hamilton@uwa.edu.au